影像组学在脑肿瘤精准诊疗中的应用和挑战

doi:10.3760/cma.j.issn.1004-4221.2018.05.018

摘要
图/表
参考文献()
相关文章 (0)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要

在强调“精准医学”的今天,对于患者和病理特异性的了解,是实施精准诊疗的关键。影像组学将提取自医学影像感兴趣区域的定量影像特征和肿瘤生物学和异质性等特征联系起来,是一种高通量定量分析方法。它提供了一种无创、便捷、动态和定量的方法了解患者的病理、基因等特异性信息。影像组学在脑肿瘤精准诊疗的应用前景巨大,可用于分子病理学诊断、定义肿瘤边界、预后和并发症的预测等,方便了对每个患者独特的疾病特征采取精确对应的预防、诊断、治疗和预后监控措施。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	白龙
	李光俊
	张月美
	柏森

关键词 ：脑肿瘤/影像组学, 脑肿瘤/精准诊疗

Abstract：

While emphasizing"Precision Medicine" nowadays, comprehending the specificity of patients and pathology is the key to achieving the precision diagnosis and treatment. Radiomics is a high-throughput quantitative analysis that combines the quantitative features from the region of interest on medical image and the biology and heterogeneity of tumor. It provides a non-invasive, convenient, dynamic, and quantitative method to collect the patient′s specific features of pathology and gene. Radiomics holds promise for the precision diagnosis and treatment of brain tumor. It can be used for molecular pathology diagnosis, definition of tumor boundaries, prognosis, prediction of complications, and so on. It helps to develop individualized measures for the prevention, diagnosis, treatment, and prognostic monitoring based on their disease features.

Key words： Brain tumor/radiomics Brain tumor/precision diagnosis and treatment

收稿日期: 2017-07-17

通讯作者: 柏森,Email:baisen@scu.edu.cn

引用本文:

白龙,李光俊,张月美等. 影像组学在脑肿瘤精准诊疗中的应用和挑战[J]. 中华放射肿瘤学杂志, 2018, 27(5): 522-526.

Bai Long,Li Guangjun,Zhang Yuemei et al. Radiomics in the precision diagnosis and treatment of brain tumor:the application and challenge[J]. Chinese Journal of Radiation Oncology, 2018, 27(5): 522-526.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2018.05.018 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2018/V27/I5/522

[1]Lambin P,Rios-Velazquez E,Leijenaar R,et al. Radiomics:extracting more information from medical images using advanced feature analysis[J].Eur J Cancer,2012,48(4):441-446.DOI:10.1016/j.ejca.2011.11.036.
[2]Kumar V,Gu YH,Basu S,et al. Radiomics:the process and the challenges[J].Magn Reson Imaging,2012,30(9):1234-1248.DOI:10.1016/j.mri.2012.06.010.
[3]Mitra S,Shankar BU.Integrating radio imaging with gene expressions toward a personalized management of cancer[J].IEEE Trans Hum Mach Syst,2014,44(5):664-677.DOI:10.1109/THMS.2014.2325744.
[4]Verma V,Simone ⅡCB,Krishnan S,et al. The rise of radiomics and implications for oncologic management[J].J Natl Cancer Inst,2017,109(7):djx055.DOI:10.1093/jnci/djx055.
[5]Lahmiri S.Glioma detection based on multi-fractal features of segmented brain MRI by particle swarm optimization techniques[J].Biomed Signal Process Control,2017,31:148-155.DOI:10.1016/j.bspc.2016.07.008.
[6]Hsieh KLC,Lo CM,Hsiao CJ.Computer-aided grading of gliomas based on local and global MRI features[J].CompuMeth Prog Biomed,2017,139:31-38.DOI:10.1016/j.cmpb.2016.10.021.
[7]Qin JB,Liu ZY,Zhang H,et al. Grading of gliomas by using radiomic features on multiple Magnetic Resonance Imaging (MRI) sequences[J].Med Sci Monit,2017,23:2168-2178.DOI:10.12659/MSM.901270.
[8]Sala E,Mema E,Himoto Y,et al. Unravelling tumour heterogeneity using next-generation imaging:radiomics,radiogenomics,and habitat imaging[J].Clin Radiol,2017,72(1):3-10.DOI:10.1016/j.crad.2016.09.013.
[9]Eisele SC,Wen PY,Lee Q.Assessment of brain tumor response:RANO and its offspring[J].Curr Treat Options Oncol,2016,17(7):35.DOI:10.1007/s11864-016-0413-5.
[10]Kotrotsou A,Zinn PO,Colen RR.Radiomics in brain tumors:an emerging technique for characterization of tumor environment[J].Magn Reson Imaging Clin N Am,2016,24(4):719-729.DOI:10.1016/j.mric.2016.06.006.
[11]Elshafeey N,Kotrotsou A,Camejo DG,et al. Multicenter study to demonstrate radiomic texture features derived from MR perfusion images of pseudoprogression compared to true progression in glioblastoma patients[J].J Clin Oncol,2017,35(15 Suppl):2016.
[12]Roelcke U,Berberat J,Mamot C,et al. P04.22 Diffusivity changes in bevacizumab-responding and refractory meningioma[J].Neu Oncol,2017,19(S3):iii45.DOI:10.1093/neuonc/nox036.162.
[13]Chen XJ,Oshima K,Schott D,et al. Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs:an exploratory study[J].PLoS One,2017,12(6):e0178961.DOI:10.1371/journal.pone.0178961.
[14]McGarry SD,Hurrell SL,Kaczmarowski AL,et al. Magnetic resonance imaging-based radiomic profiles predict patient prognosis in newly diagnosed glioblastoma before therapy[J].Tomography,2016,2(3):223-228.DOI:10.18383/j.tom.2016.00250.
[15]Wibmer A,Hricak H,Gondo T,et al. Haralick texture analysis of prostate MRI:utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores[J].Eur Radiol,2015,25(10):2840-2850.DOI:10.1007/s00330-015-3701-8.
[16]Beig N,Patel J,Prasanna P,et al. Radiogenomic analysis of hypoxia pathway reveals computerized MRI descriptors predictive of overall survival in Glioblastoma[A]//Proceedings of SPIE Volume 10134,Medical Imaging 2017:Computer-Aided Diagnosis[C].Orlando,Florida,United States:SPIE,2017:101341U.DOI:10.1117/12.2255694.
[17]Kickingereder P,Götz M,Muschelli J,et al. Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response[J].Clin Cancer Res,2016,22(23):5765-5771.DOI:10.1158/1078-0432.CCR-16-0702.
[18]Lohmann P,Stoffels G,Ceccon G,et al. Radiation injury vs.recurrent brain metastasis:combining textural feature radiomics analysis and standard parameters may increase ¹⁸F-FET PET accuracy without dynamic scans[J].Eur Radiol,2017,27(7):2916-2927.DOI:10.1007/s00330-016-4638-2.
[19]Chen Y,Argentinis JDE,Weber G.IBM Watson:how cognitive computing can be applied to big data challenges in life sciences research[J].Clin Ther,2016,38(4):688-701.DOI:10.1016/j.clinthera.2015.12.001.
[20]中国脑胶质瘤协作组,中国脑胶质瘤基因组图谱计划.中国脑胶质瘤分子诊疗指南[J].中华神经外科杂志,2014,30(5):435-444.DOI:10.3760/cma.j.issn.1001-2346.2014.05.002.
Chinese glioma collaboration group. Chinese glioma genome mapping program-Guidelines for molecular diagnosis and treatment of Chinese gliomas[J].Chin J Neurosurg,2014,30(5):435-444.DOI:10.3760/cma.j.issn.1001-2346.2014.05.002.
[21]Pope WB,Prins RM,Thomas MA,et al. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy[J].J Neuro Oncol,2012,107(1):197-205.DOI:10.1007/s11060-011-0737-8.
[22]Drabycz S,Roldán G,De Robles P,et al. An analysis of image texture,tumor location,and MGMT promoter methylation in glioblastoma using magnetic resonance imaging[J].NeuroImage,2010,49(2):1398-1405.DOI:10.1016/j.neuroimage.2009.09.049.
[23]Andreassen CN,Schack LMH,Laursen LV,et al. Radiogenomics–current status,challenges and future directions[J].Cancer Lett,2016,382(1):127-136.DOI:10.1016/j.canlet.2016.01.035.
[24]Colen RR,Hassan I,Elshafeey N,et al. Shedding light on the 2016 World Health Organization classification of tumors of the central nervous system in the era of radiomics and radiogenomics[J].Magn Reson Imaging Clin N Am,2016,24(4):741-749.DOI:10.1016/j.mric.2016.07.001.
[25]Bonte S,Goethals I,Van Holen R.An automatic and flexible brain tumour segmentation algorithm using abnormality detection for radiomics applications[A]//Proceedings of the 18^th Symposium of the Belgian Society of Nuclear Medicine[C].Ghent,Belgium:Belgian Society of Nuclear Medicine,2017.
[26]Cheng Y,Fu XL,Liu J,et al. P2.03b-006 distinct MR imaging features of metastatic lesions in brain with Non-small cell lung cancer according to EGFR mutation status[J].J Thorac Oncol,2017,12(S1):S935-S936.DOI:10.1016/j.jtho.2016.11.1287.
[27]Nardone V,Tini P,Biondi M,et al. Prognostic value of MR imaging texture analysis in brain non-small cell lung cancer oligo-metastases undergoing stereotactic irradiation[J].Cureus,2016,8(4):e584.DOI:10.7759/cureus.584.
[28]Li ZJ,Mao Y,Li HS,et al. Differentiating brain metastases from different pathological types of lung cancers using texture analysis of T1 postcontrast MR[J].Magn Reson Med,2016,76(5):1410-1419.DOI:10.1002/mrm.26029.
[29]Yip SSF,Aerts HJWL.Applications and limitations of radiomics[J].Phys Med Biol,2016,61(13):R150-R166.DOI:10.1088/0031-9155/61/13/R150.
[30]Hyare H,Thust S,Rees J.Advanced MRI techniques in the monitoring of treatment of gliomas[J].Curr Treat Options Neurol,2017,19(3):11.DOI:10.1007/s11940-017-0445-6.
[31]Abrol S,Kotrotsou A,Salem A,et al. Radiomic phenotyping in brain cancer to unravel hidden information in medical images[J].Top Magn Reson Imaging,2017,26(1):43-53.DOI:10.1097/RMR.0000000000000117.
[32]Lee J,Jain R,Khalil K,et al. Texture feature ratios from relative CBV maps of perfusion MRI are associated with patient survival in glioblastoma[J].Am J Neuroradiol,2016,37(1):37-43.DOI:10.3174/ajnr. A4534.
[33]Nachimuthu DS,Baladhandapani A.Multidimensional texture characterization:on analysis for brain tumor tissues using MRS and MRI[J].J Digit Imaging,2014,27(4):496-506.DOI:10.1007/s10278-013-9669-5.
[34]Galavis PE,Hollensen C,Jallow N,et al. Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters[J].Acta Oncol,2010,49(7):1012-1016.DOI:10.3109/0284186X.2010.498437.
[35]Shiri I,Abdollahi H,Shaysteh S,et al. Test-retest reproducibility and robustness analysis of recurrent glioblastoma MRI radiomics texture features[J].Iran J Radiol,2017(5):e48035.DOI:10.5812/iranjradiol.48035.
[36]Wang J,Wu CJ,Bao ML,et al. Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2 in clinically relevant prostate cancer[J].Eur Radiol,2017,27(10):4082-4090.DOI:10.1007/s00330-017-4800-5.
[37]Li ZC,Li QH,Song BL,et al. Clustering of MRI radiomics features for glioblastoma multiforme:an initial study[A]//Proceedings of the 7^th International Conference on Medical Imaging and Virtual Reality[C].Bern,Switzerland:Springer,2016:311-319.DOI:10.1007/978-3-319-43775-0_28.
[38]Narang S,Lehrer M,Yang DL,et al. Radiomics in glioblastoma:current status,challenges and potential opportunities[J].Transl Cancer Res,2016,5(4):383-397.DOI:10.21037/tcr.2016.06.31.
[39]Clarke LP,Nordstrom RJ,Zhang HM,et al. The quantitative imaging network:NCI′s historical perspective and planned goals[J].Transl Oncol,2014,7(1):1-4.DOI:10.1593/tlo.13832.
[40]Bibault JE,Giraud P,Burgun A.Big Data and machine learning in radiation oncology:state of the art and future prospects[J].Cancer Lett,2016,382(1):110-117.DOI:10.1016/j.canlet.2016.05.033.